Novavax still plans to push RSV vaccine to market after failed trial

The Gaithersburg biotech said it will take more time and cash than expected.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.